HOXA11 and neoplasm: Based on previous reports, we concluded that HOXA11-AS function as an oncogenic or tumor promotive regulator in several types of human cancers [15–21], such as colorectal cancer, lung cancer, hepatocellular carcinoma, glioma, breast cancer, renal cancer, ovarian cancer, melanoma, and gastric cancer.